Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma.
Recommended Citation
Zhang L, Yang M, Mayer T, Johnstone B, Les C, Frisch N, Parsons T, Mi QS, and Gibson G. Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma. Connect Tissue Res 2017; 58(2):155-161
Document Type
Article
Publication Date
3-1-2017
Publication Title
Connective tissue research
Abstract
Establishing a definitive diagnosis between benign enchondroma versus low-grade chondrosarcoma presents a potential challenge to both clinicians and pathologists. microRNAs (small non-coding RNAs) have proven to be effective biomarkers for the identification of tumors and tumor progression. We present analysis, both array and quantitative PCR, that shows consistently and substantially increased expression of two microRNAs, miRs-181a and -138, in low-grade chondrosarcomas compared with enchondromas. The data suggest these microRNAs would provide an analytical distinction between the chondrosarcoma and benign neoplasms that can be performed in formalin-fixed paraffin-embedded specimens. Together with recent publications, these data indicate that miRs-181a and -138 also play a role in tumor development and homeostasis and may provide new targets for the development of much needed therapeutic intervention.
Medical Subject Headings
Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chondroma; Chondrosarcoma; Female; Humans; Male; MicroRNAs; Middle Aged; RNA, Neoplasm
PubMed ID
27267924
Volume
58
Issue
2
First Page
155
Last Page
161
